All News
Filter News
Found 387 articles
-
Together with Siemens Healthineers, Varian Showcases Technologies and Services Spanning the Full Cancer Care Continuum at ASTRO 2022
10/20/2022
Varian, a Siemens Healthineers company, is highlighting its portfolio of intelligent, end-to-end imaging and cancer care technologies and services during the 2022 American Society for Radiation Oncology annual meeting taking place from October 23-26 in San Antonio, Texas.
-
The third quarter of 2022 saw continued job cuts, a shift in focus away from COVID-19, an unexpected boost in the Alzheimer’s research space and increased scrutiny of accelerated approvals.
-
Edesa Biotech Reports Statistically Significant Mortality Reductions in Phase 2 ARDS Drug Study
9/30/2022
Edesa Biotech, Inc. announced final results from the Phase 2 portion of its ongoing Phase 2/Phase 3 clinical study.
-
IMV Provides an Update on The VITALIZE Trial
9/30/2022
IMV Inc. today provided an update on the open-label VITALIZE study evaluating its lead product maveropepimut-S (MVP-S) in combination with pembrolizumab and intermittent low-dose cyclophosphamide (CPA) in patients with relapses, refractory diffuse large B cell lymphoma (r/r DLBCL).
-
Advances in immuno-oncology and adaptive cell therapy that began about a decade ago are enabling fresh, biology-driven approaches to bring therapeutic cancer vaccines closer to fruition.
-
Six months after its launch, Vesalius Therapeutics is laying off 43% of its staff. With a current staff of 67, the company is slashing 29 jobs.
-
Both Bristol Myers Squibb and AbbVie filed a WARN notice with the California state government stating they intend to lay off up to 360 people.
-
IMV Inc. Announces Strategic Reorganization
9/15/2022
IMV Inc. today announced a strategic reorganization together with the appointment of Dr. Saman Maleki to the Company’s Board of Directors and promotion of Brittany Davison to Chief Accounting Officer.
-
IMV Inc. to Present at Two Investor Conferences in September 2022
9/1/2022
IMV Inc., a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers, announced that members of IMV’s executive management team will be presenting at two investor conferences in September.
-
Multiple Myeloma Market Share and Growth Factors Impact Analysis 2021 – 2031
8/19/2022
Wilmington, Delaware, United States, Transparency Market Research Inc. – The multiple myeloma market is likely to witness promising growth across the forecast period of 2021-2031 on the back of the growing prevalence of blood cancer around the world.
-
IMV Inc. Announces Second Quarter 2022 Financial and Operational Results
8/11/2022
IMV Inc. today announced its financial and operational results and provided an update for the second quarter ended June 30, 2022.
-
IMV Inc. to Announce Second Quarter 2022 Results and Host a Conference Call and Webcast on August 11, 2022
8/4/2022
IMV Inc. today announced that it will hold a conference call and webcast on Thursday, August 11, 2022, at 8:00 a.m. ET to discuss the company’s 2022 second quarter financial.
-
Positive Clinical Results for Bluejay’s Symphony IL-6 Test Presented at AACC 2022
7/27/2022
Bluejay Diagnostics, Inc. today announced that positive results of analytical and clinical studies of Bluejay’s Symphony IL-6 Test were presented at AACC 2022, the leading industry conference for clinical laboratory medicine.
-
IMV announces the first wave of 2022 IMV ServiceTrak™ Clinical Laboratory Awardees at AACC 2022
7/26/2022
Today IMV, part of Science and Medicine Group, the leading market research and business intelligence provider to the laboratory diagnostic industry, announced the first wave of category winners of the 2022 IMV ServiceTrak™ Clinical Laboratory Awards.
-
Network Point-of-Care Glucose Testing Market Size | US$ 3.3 Billion by 2030
7/22/2022
The global Network Point-of-Care Glucose Testing market size is expected to be surpass around US$ 5.6 billion by 2030 from valued at US$ 3.3 billion in 2020 and is anticipated to grow at a CAGR of 5.10% from 2021 to 2030.
-
3D Laparoscopy Imaging Systems Market Size, Growth, Trends | Report 2022-2030
7/19/2022
According to Vision research Reports, the global 3D laparoscopy imaging systems market was surpassed at USD 3.98 billion in 2021 and is expected to hit around USD 6.5 billion by 2030, growing at a CAGR of 5.6% from 2022 to 2030.
-
Horizon Technology Finance Provides Second Quarter 2022 Portfolio Update
7/13/2022
Horizon Technology Finance Corporation (NASDAQ: HRZN) ("HRZN" or the "Company"), today provided its portfolio update for the second quarter ended June 30, 2022 and an update on the lending platform ("Horizon Platform") of Horizon Technology Finance Management LLC ("HTFM"), its investment adviser.
-
Medical Device Outsourcing Market Size to Reach US$ 291.93 Billion by 2030
7/12/2022
According to Vision Research Reports, the global medical device outsourcing market size was valued at USD 106.92 billion in 2021, and is predicted to be worth around USD 291.93 billion by 2030, registering a CAGR of 11.1% during the forecast period 2022 to 2030.
-
Endoscopy Devices Market Size, CAGR, Trends | Forecast Report 2030
7/7/2022
According to Vision Research Reports, the global endoscopy devices market size is expected to be worth around US$ 72.9 billion by 2030.
-
U.S. Behavioral Health Care Software and Services Market Size, Report 2022-2030
6/28/2022
The U.S. behavioral health care software and services market was surpassed at USD 1.2 billion in 2021 and is expected to hit around USD 3.3 billion by 2030, growing at a CAGR of 11.9% from 2022 to 2030.